An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers

Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endo...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoliang Qi, Yajing Xiang, Ying Li, Jiajia Wang, Yuxi Chen, Yulong Lan, Jinsong Liu, Jianliang Shen
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-03-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X24005206
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586261799370752
author Xiaoliang Qi
Yajing Xiang
Ying Li
Jiajia Wang
Yuxi Chen
Yulong Lan
Jinsong Liu
Jianliang Shen
author_facet Xiaoliang Qi
Yajing Xiang
Ying Li
Jiajia Wang
Yuxi Chen
Yulong Lan
Jinsong Liu
Jianliang Shen
author_sort Xiaoliang Qi
collection DOAJ
description Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endogenous ATP-activated prodrug system (termed ISD3) consisting of nanoparticles (indole-3-acetic acid/zeolitic imidazolate framework-8@polydopamine@platinum, IZPP) embedded in a silk fibroin-based hydrogel, aimed at treating multidrug-resistant (MDR) bacteria-infected pressure ulcers. Initially, an ultraviolet-triggered adhesive ISD3 barrier is formed over the pressure ulcer wound by a simple local injection. Subsequently, the bacteria-secreted ATP prompts the degradation of IZPP, allowing the loaded IAA prodrug and nanozyme to encounter spatiotemporally on a single carrier, thereby efficiently generating reactive oxygen species (ROS). Exposure to 808 nm near-infrared light enhances the catalytic reaction speed, boosting ROS levels for stronger antibacterial action. Once optimal antibacterial action is reached, ISD3 switches to a dormant state, halting any further ROS production. Moreover, the bioactive components in ISD3 can exert anti-inflammatory functions, aiding in pressure ulcer recovery. Overall, our research introduces a hydrogel prodrug strategy activated by bacterial endogenous ATP, which precisely manages ROS generation and accelerates the recovery of MDR bacteria-infected pressure ulcers.
format Article
id doaj-art-5afc99cb45c44bd39585ea64182fd170
institution Kabale University
issn 2452-199X
language English
publishDate 2025-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Bioactive Materials
spelling doaj-art-5afc99cb45c44bd39585ea64182fd1702025-01-26T05:04:25ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2025-03-0145301321An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcersXiaoliang Qi0Yajing Xiang1Ying Li2Jiajia Wang3Yuxi Chen4Yulong Lan5Jinsong Liu6Jianliang Shen7National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaNational Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China; Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, China; Corresponding author. National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endogenous ATP-activated prodrug system (termed ISD3) consisting of nanoparticles (indole-3-acetic acid/zeolitic imidazolate framework-8@polydopamine@platinum, IZPP) embedded in a silk fibroin-based hydrogel, aimed at treating multidrug-resistant (MDR) bacteria-infected pressure ulcers. Initially, an ultraviolet-triggered adhesive ISD3 barrier is formed over the pressure ulcer wound by a simple local injection. Subsequently, the bacteria-secreted ATP prompts the degradation of IZPP, allowing the loaded IAA prodrug and nanozyme to encounter spatiotemporally on a single carrier, thereby efficiently generating reactive oxygen species (ROS). Exposure to 808 nm near-infrared light enhances the catalytic reaction speed, boosting ROS levels for stronger antibacterial action. Once optimal antibacterial action is reached, ISD3 switches to a dormant state, halting any further ROS production. Moreover, the bioactive components in ISD3 can exert anti-inflammatory functions, aiding in pressure ulcer recovery. Overall, our research introduces a hydrogel prodrug strategy activated by bacterial endogenous ATP, which precisely manages ROS generation and accelerates the recovery of MDR bacteria-infected pressure ulcers.http://www.sciencedirect.com/science/article/pii/S2452199X24005206Prodrug systemsAdenosine triphosphate responseHydrogelsMultidrug-resistant bacterial infectionPressure ulcers
spellingShingle Xiaoliang Qi
Yajing Xiang
Ying Li
Jiajia Wang
Yuxi Chen
Yulong Lan
Jinsong Liu
Jianliang Shen
An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
Bioactive Materials
Prodrug systems
Adenosine triphosphate response
Hydrogels
Multidrug-resistant bacterial infection
Pressure ulcers
title An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
title_full An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
title_fullStr An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
title_full_unstemmed An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
title_short An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
title_sort atp activated spatiotemporally controlled hydrogel prodrug system for treating multidrug resistant bacteria infected pressure ulcers
topic Prodrug systems
Adenosine triphosphate response
Hydrogels
Multidrug-resistant bacterial infection
Pressure ulcers
url http://www.sciencedirect.com/science/article/pii/S2452199X24005206
work_keys_str_mv AT xiaoliangqi anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yajingxiang anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yingli anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jiajiawang anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yuxichen anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yulonglan anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jinsongliu anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jianliangshen anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT xiaoliangqi atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yajingxiang atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yingli atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jiajiawang atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yuxichen atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT yulonglan atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jinsongliu atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers
AT jianliangshen atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers